Rilzabrutinib Medical Launch Lead

Role Summary

Leads medical strategy for the Rilzabrutinib launch within the Global Development Team, serving as Medical Lead on the program. Drives pre-launch medical activities and coordinates with internal and external stakeholders to develop and implement strategic medical plans during waive-1 of regulatory submissions and approvals. Reports to the Global Head of Rare Launch and Pipeline Portfolio within the Global Medical Rare Disease Organization.

Responsibilities

• Accountable for developing and implementing the Global Brand Medical strategy and action plan for Rilzabrutinib's implementation of the medical strategy globally.
• Serve as Medical representative, providing appropriate cross-functional expertise and ensuring execution of critical medical strategies within the Rilzabrutinib Global Development Team.
• Lead strategy behind the Evidence Generation Plan to support product development, working alongside the Medical Evidence Generation team, Global Product Team, and Rilzabrutinib Medical Director
• Drive the development and Global execution of the Managed Access Program for Rilzabrutinib in ITP and wAIHA.
• Define the Global strategy for Clinical Insights, KOL mapping, and Message dissemination.
• Provide Medical expertise for the design and execution of potential new clinical studies, considering clinically relevant, patient-centric outcomes.
• Lead Medical responsibilities within the Global Labelling process across Rilzabrutinib indications.
• Contribute to planning, resourcing, and budget decisions for implementing the Global Medical Roadmap for the launch of Rilzabrutinib across indications.

Qualifications

• Medical degree or PhD preferred, with expertise in Rare Hematologic Disorders
• Global and peer recognition as an opinion leader in one’s area of expertise
• Considerable experience in evidence generation, including clinical development and/or real-world evidence (10+ years)
• Proficient in public speaking, with demonstrated facility in interacting with high-stakes external stakeholders (health authorities, scientific and medical societies)
• Demonstrated ability to work effectively and lead through influence in a matrixed environment and across geographies and cultures
• Previous experience in leading teams and budget management is preferred.